Supernus Pharmaceuticals, Inc.
Clinical trials sponsored by Supernus Pharmaceuticals, Inc., explained in plain language.
-
Experimental drug offers hope for patients with unstoppable seizures
Disease control NO_LONGER_AVAILABLEThis study provided expanded access to an experimental drug called SAGE-547 for patients with super-refractory status epilepticus—a severe, life-threatening condition where seizures continue despite multiple standard treatments. The trial aimed to evaluate whether a continuous in…
Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for moms: depression treatment opens to more women
Disease control APPROVED_FOR_MARKETINGThis program provides access to ZULRESSO (brexanolone) injection for women with postpartum depression before it's widely available. Eligible adult women with postpartum depression can receive this treatment through their healthcare provider. The program requires careful medical s…
Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC